Emcure Pharmaceuticals Limited (BOM: 544210)
India
· Delayed Price · Currency is INR 1,368.55
-20.55 (-1.48%)
At close: Dec 20, 2024
Emcure Pharmaceuticals Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Net Income | 5,673 | 4,982 | 5,320 | 6,622 | 3,921 | 836.07 | Upgrade
|
| Depreciation & Amortization | 3,562 | 3,032 | 2,512 | 2,348 | 3,137 | 3,114 | Upgrade
|
| Other Amortization | 92.56 | 92.56 | 89.04 | 100.28 | 96.1 | 94.62 | Upgrade
|
| Loss (Gain) From Sale of Assets | -451.29 | -71.92 | 3.33 | 4.08 | -4.23 | 41.57 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | 436.95 | 39.83 | Upgrade
|
| Loss (Gain) From Sale of Investments | -56.07 | -25.32 | -1.21 | - | - | - | Upgrade
|
| Stock-Based Compensation | 30.28 | 39.67 | 52.76 | 57.16 | 63.48 | 144.19 | Upgrade
|
| Other Operating Activities | 2,708 | 2,419 | 2,415 | 1,469 | 4,573 | 1,973 | Upgrade
|
| Change in Accounts Receivable | -3,459 | -1,506 | -3,398 | -1,729 | -3,301 | -1,732 | Upgrade
|
| Change in Inventory | -2,595 | -267.61 | 663.85 | -3,072 | -3,413 | -454.05 | Upgrade
|
| Change in Accounts Payable | 4,302 | 1,543 | -391.8 | 3,157 | 2,315 | 553.62 | Upgrade
|
| Change in Other Net Operating Assets | -773.93 | 736.2 | 203.54 | -1,276 | 1,053 | 392.41 | Upgrade
|
| Operating Cash Flow | 9,032 | 10,972 | 7,469 | 7,682 | 7,044 | 5,003 | Upgrade
|
| Operating Cash Flow Growth | -18.78% | 46.91% | -2.78% | 9.05% | 40.80% | 3.66% | Upgrade
|
| Capital Expenditures | -2,449 | -2,758 | -3,906 | -3,782 | -1,254 | -1,153 | Upgrade
|
| Sale of Property, Plant & Equipment | 604.22 | 315.37 | 12.75 | 31.21 | 125.14 | 166.14 | Upgrade
|
| Cash Acquisitions | -3,451 | -3,451 | - | -2,751 | -1,116 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -961.34 | -313.6 | -127.67 | -187.87 | -202.65 | -393.48 | Upgrade
|
| Investment in Securities | -4,237 | -1,098 | -708.36 | -1,308 | -147.22 | -270.45 | Upgrade
|
| Other Investing Activities | 5,869 | 179.46 | 152.4 | 109.49 | 75.81 | 13.22 | Upgrade
|
| Investing Cash Flow | -4,626 | -7,125 | -4,577 | -7,888 | -2,518 | -1,638 | Upgrade
|
| Short-Term Debt Issued | - | 1,025 | 976.79 | 1,759 | - | 1,772 | Upgrade
|
| Long-Term Debt Issued | - | 5,474 | 3,576 | 3,714 | 5,775 | 1,952 | Upgrade
|
| Total Debt Issued | 5,145 | 6,500 | 4,553 | 5,473 | 5,775 | 3,725 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -981.67 | - | Upgrade
|
| Long-Term Debt Repaid | - | -5,310 | -3,777 | -4,814 | -4,548 | -4,067 | Upgrade
|
| Total Debt Repaid | -10,959 | -5,310 | -3,777 | -4,814 | -5,529 | -4,067 | Upgrade
|
| Net Debt Issued (Repaid) | -5,814 | 1,190 | 775.24 | 659.17 | 245.66 | -342.45 | Upgrade
|
| Issuance of Common Stock | 7,728 | 76.6 | - | - | - | - | Upgrade
|
| Common Dividends Paid | -361.7 | -542.55 | -361.71 | -542.55 | -180.85 | -452.13 | Upgrade
|
| Dividends Paid | -361.7 | -542.55 | -361.71 | -542.55 | -180.85 | -452.13 | Upgrade
|
| Other Financing Activities | -2,223 | -2,366 | -1,868 | -1,635 | -1,954 | -2,211 | Upgrade
|
| Financing Cash Flow | -669.81 | -1,642 | -1,454 | -1,519 | -1,889 | -3,005 | Upgrade
|
| Foreign Exchange Rate Adjustments | -18.76 | -20.02 | -1.28 | 1.86 | -46.17 | -41.74 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | -100 | 2,141 | - | - | Upgrade
|
| Net Cash Flow | 3,717 | 2,185 | 1,336 | 418.7 | 2,591 | 318.56 | Upgrade
|
| Free Cash Flow | 6,582 | 8,215 | 3,563 | 3,900 | 5,790 | 3,850 | Upgrade
|
| Free Cash Flow Growth | -14.51% | 130.58% | -8.65% | -32.65% | 50.40% | 147.08% | Upgrade
|
| Free Cash Flow Margin | 9.07% | 12.34% | 5.95% | 6.66% | 11.50% | 7.63% | Upgrade
|
| Free Cash Flow Per Share | 36.00 | 45.42 | 19.70 | 21.56 | 32.02 | 21.29 | Upgrade
|
| Cash Interest Paid | 1,959 | 2,082 | 1,786 | 1,553 | 1,845 | 2,024 | Upgrade
|
| Cash Income Tax Paid | 2,604 | 2,237 | 2,005 | 3,112 | 2,004 | 977.27 | Upgrade
|
| Levered Free Cash Flow | 2,585 | 3,722 | 1,763 | 2,388 | 5,053 | 2,793 | Upgrade
|
| Unlevered Free Cash Flow | 3,765 | 4,940 | 2,781 | 3,216 | 5,765 | 4,072 | Upgrade
|
| Change in Net Working Capital | 2,489 | 885.42 | 1,598 | 2,104 | 2,092 | 179.72 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.